科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background and Objectives: With improvements in imaging technologies. pancreatic cystic lesions (PCLs) have been increasingly identified in recent years. However. the imaging modalities used to differentiate the categories of pancreatic cysts remain limited, which may cause confusion when planning treatment. Due to progress in endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) technology. auxiliary diagnosis by the detection of cystic fluid has become a recent trend. Methods: From March 2015 to April 2016. 120 patients with PCLs were enrolled in this study. According to the results of EUS. cyst fluid carcinoembryonic antigen (CEA) analysis, and cystic fluid cytology. the patients were divided into two groups: a nonmucinous and a mucinous group. Of those 61 patients who had undergone surgical resection were included in the analysis. The clinical features. biochemical and tumor markers of cyst fluid as well as the cytological test results of the patients were compared with histopathology results. Results: A cyst size of 4.0 cm was used as the boundary value: a cyst <= 4.0 cm was defined as a small PCL. 87 (72.5%) lesions were <= 4.0 cm, and 33 (27.5%) lesions were >4.0 cm. Regarding the analysis of CEA and carbohydrate antigens 19-9 (CA19-9). significant differences were found between the nonmucinous and mucinous groups (P < 0.05) according to nonparametric independent samples tests. The EUS, cystic fluid CEA. and cystic fluid cytology results were compared with the tissue pathology findings using McNemar's test (P < 0.05) and showed a sensitivity of 90% and a specificity of 84%. Conclusion: A diagnostic combination of EUS. cyst fluid CEA, and cystic fluid cytology could be used to differentiate small pancreatic cystic neoplasms. Cystic fluid cytology analysis is helpful for planning treatment for pancreatic Cystic tumors that pose a surgical risk.
- 出版日期2018-10
- 单位首都医科大学; 中国人民解放军总医院
